Emma Rothkopf
Papers
1
Total Citations
9
H-Index
1
About
Dr. Emma Rothkopf is a rising leader in the field of bioanalytical chemistry and clinical psychopharmacology, with a focused expertise in therapeutic drug monitoring for mental health treatments. Her most impactful work provides a critical bridge between pharmacology and personalized medicine, addressing the global challenge of matching patients with effective antidepressants. In her landmark 2023 study, "An in-depth analysis of four classes of antidepressants quantification from human serum using LC–MS/MS," Dr. Rothkopf developed a highly sensitive and robust method for simultaneously measuring multiple drug classes in human serum. This work is foundational for enabling clinicians to precisely tailor dosages and reduce the trial-and-error process that often plagues depression treatment. Garnering 9 citations in its first year, this paper is already shaping best practices in clinical labs. By tackling the growing crisis of depression—where female diagnosis rates are disproportionately high and prescriptions have tripled—Dr. Rothkopf’s contributions are directly improving patient outcomes through rigorous analytical science.
Research Focus
Key Achievements
Top Papers
- 1